1-6 of 6
Xiaoting Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4597: RNA m1A methyltransferase TRMT61A induces MAPK/ERK signaling and is a therapeutic target in colorectal cancer

Xiaoting Zhang, Na Qin, Fenfen Ji, Hao Su, Hongyan Chen, Haiyun Shang, Huarong Chen
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4597.
https://doi.org/10.1158/1538-7445.AM2024-4597
Published: 22 March 2024
View article titled, Abstract 4597: RNA m<sup>1</sup>A methyltransferase TRMT61A induces MAPK/ERK signaling and is a therapeutic target in colorectal cancer
Journal Articles

HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1

Yongguang Yang, Marissa Leonard, Yijuan Zhang, Dan Zhao, Charif Mahmoud, Shugufta Khan, Jiang Wang, Elyse E. Lower, Xiaoting Zhang
Journal: Cancer Research
Cancer Res (2018) 78 (2): 422–435.
https://doi.org/10.1158/0008-5472.CAN-17-1533
Published: 15 January 2018
View article titled, HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1
Open the PDF for HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1 in another window
Includes: Supplementary data
Journal Articles

Abstract 1000: Estrogen receptor coactivator MED1 in breast tumorigenesis and therapeutic resistance

Xiaoting Zhang
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1000.
https://doi.org/10.1158/1538-7445.AM2017-1000
Published: 01 July 2017
View article titled, Abstract 1000: Estrogen receptor coactivator MED1 in breast tumorigenesis and therapeutic resistance
Journal Articles

Abstract P3-05-16: The effect of HER-2/neu inhibition on prolonging clinical benefit with fulvestrant treatment for metastatic estrogen receptor positive breast cancer patients treated with trastuzumab

Mahmoud Charif, Elyse E Lower, Diane Kennedy, Harriet Kumar, Shugufta Khan, Neetu Radhakrishnan, Xiaoting Zhang
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P3-05-16.
https://doi.org/10.1158/1538-7445.SABCS14-P3-05-16
Published: 01 May 2015
View article titled, Abstract P3-05-16: The effect of HER-2/neu inhibition on prolonging clinical benefit with fulvestrant treatment for metastatic estrogen receptor positive breast cancer patients treated with trastuzumab
Journal Articles

Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells

Jiajun Cui, Katherine Germer, Tianying Wu, Jiang Wang, Jia Luo, Shao-chun Wang, Qianben Wang, Xiaoting Zhang
Journal: Cancer Research
Cancer Res (2012) 72 (21): 5625–5634.
https://doi.org/10.1158/0008-5472.CAN-12-1305
Published: 31 October 2012
View article titled, Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells
Open the PDF for Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Abstract 2918: Estrogen receptor coactivator MED1 in mammary progenitor/stem cell determination and tamoxifen resistance of breast cancer

Xiaoting Zhang
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2918.
https://doi.org/10.1158/1538-7445.AM2012-2918
Published: 15 April 2012
View article titled, Abstract 2918: Estrogen receptor coactivator MED1 in mammary progenitor/stem cell determination and tamoxifen resistance of breast cancer